Main news

 


 

Evaluation of the World Health Organization-HEARTS hypertension control package in Bangladesh: a quasi-experimental trial
Evaluation of the World Health Organization-HEARTS hypertension control package in Bangladesh: a quasi-experimental trial The World Health Organization (WHO) promotes the HEARTS technical package for improving hypertension control worldwide, but its effectiveness has not been rigorously evaluated.


Common Eye Disorder May Be Linked to Maternal Hypertension
Common Eye Disorder May Be Linked to Maternal Hypertension Children whose mothers have a hypertensive disorder in pregnancy (HDP) may have an increased risk for strabismus, including exophoria and intermittent exotropia, new research shows. Preeclampsia and poorly controlled blood pressure may confer the greatest risk.


Editorial Activity

cardiology book

New Tool to Guide Transcatheter Aortic Valve Replacement
New Tool to Guide Transcatheter Aortic Valve Replacement Researchers developed TJ-ICE–guided TAVR to facilitate implanting a heart valve at an optimal depth, guided by direct visualization of the membranous septum (MS) during the procedure.


Redefining CVD Risk: Cardiovascular-Kidney-Metabolic (CKM) Syndrome
Redefining CVD Risk: Cardiovascular-Kidney-Metabolic (CKM) Syndrome Citing the strong overlap between heart disease, kidney disease, type 2 diabetes, and obesity, the American Heart Association (AHA) has for the first time formally defined what they are calling cardiovascular-kidney-metabolic (CKM) syndrome.


ACP Revises Standard on Cardiorespiratory Death Determination
ACP Revises Standard on Cardiorespiratory Death Determination The American College of Physicians (ACP) has issued a new position paper on determination of death that includes a clarification to the 1981 Uniform Determination of Death Act (UDDA), but otherwise reaffirms the current standards.


AHA Updates CPR Guidelines on Cardiac Arrest After Poisoning
AHA Updates CPR Guidelines on Cardiac Arrest After Poisoning The American Heart Association (AHA) has released a focused update on managing patients with cardiac arrest or life-threatening toxicity due to poisoning. The update reflects treatment advances and new knowledge, including the use of venoarterial extracorporeal membrane oxygenation (VA-ECMO) for patients whose condition is refractory to poison antidotes and other therapies.


Nobel Prize Awarded to Covid Vaccine Pioneers
Nobel Prize Awarded to Covid Vaccine Pioneers The physiology or medicine prize for Katalin Karikó and Drew Weissman recognized work that led to the development of vaccines that were administered to billions around the world.


Main results of the 2023 European Society of Cardiology Congress
Main results of the 2023 European Society of Cardiology Congress The next annual Congress of the European Society of Cardiology was held in a hybrid format (onsite and online) from August 25 to 28, 2023 inAmsterdam (Netherlands). About 31,000 specialists from 150 countries took part in the event. Traditionally, the most anticipated events at the congress are the scientific HOT LINE sessions, where the results of the most important clinical trials are presented for the first time.clinical trials. This year, participants had the opportunity to learn about 29 specially selected randomised trials in 9 sessions over 4 days.


ESC Issues First Comprehensive Cardiomyopathy Guidelines
ESC Issues First Comprehensive Cardiomyopathy Guidelines The European Society of Cardiology has released new guidelines for cardiomyopathies, their first major comprehensive international guidelines to address diagnosis and treatment of the broad causes of heart muscle dysfunction.


AHA/ACC Issue Updated Chronic Coronary Disease Guidelines
AHA/ACC Issue Updated Chronic Coronary Disease Guidelines The latest clinical practice guideline for managing patients with chronic coronary disease (CCD) takes an evidence-based and patient-centered approach to care and includes key updates on revascularization, beta-blocker use, and routine functional and anatomic testing. Developed by the American Heart Association (AHA), the American College of Cardiology (ACC), and other specialty societies, the 2023 guideline both updates and consolidates ACC/AHA guidelines previously published in 2012 and 2014 for the management of patients with stable ischemic heart disease.